Table 5. Standardized incidence ratios (SIRs) for specific cancer types stratified by time after tuberculosis diagnosis among male and female patients.
|
<1 Year |
1–5 Years |
>5 Years |
||||
|---|---|---|---|---|---|---|
| Site of cancers | Observed | SIR (95% CI) | Observed | SIR (95% CI) | Observed | SIR (95% CI) |
|
Male | ||||||
| Head and neck | 14 | 3.74 (2.05–6.28) | 15 | 1.48 (0.83–2.44) | 8 | 1.61 (0.69–3.17) |
| Esophagus | 8 | 6.96 (3.01–13.72) | 6 | 1.96 (0.72–4.26) | 3 | 2.05 (0.42–6.00) |
| Colon and rectum | 14 | 2.18 (1.19–3.65) | 18 | 1.06 (0.63–1.68) | 12 | 1.46 (0.75–2.55) |
| Liver | 17 | 2.72 (1.59–4.36) | 31 | 1.90 (1.29–2.70) | 13 | 1.73 (0.92–2.96) |
| Biliary tract | 2 | 3.77 (0.46–13.62) | 5 | 3.66 (1.19–8.54) | 2 | 3.15 (0.38–11.37) |
| Lung | 85 | 12.39 (9.90–15.33) | 39 | 2.21 (1.57–3.02) | 10 | 1.21 (0.58–2.23) |
| Melanoma | 2 | 15.39 (1.86–55.59) | 2 | 5.86 (0.71–21.16) | 0 | 0.00 (0.00–23.77) |
| Bladder | 3 | 1.47 (0.30–4.30) | 9 | 1.71 (0.78–3.24) | 9 | 3.64 (1.67–6.92) |
| Hodgkin's disease |
2 |
58.21 (7.05–210.27) |
0 |
0.00 (0.00–44.57) |
0 |
0.00 (0.00–95.18) |
|
Female | ||||||
| Esophagus | 3 | 52.11 (10.75–152.28) | 0 | 0.00 (0.00–25.96) | 0 | 0.00 (0.00–51.79) |
| Lung | 21 | 17.24 (10.67–26.36) | 3 | 0.95 (0.20–2.77) | 1 | 0.60 (0.02–3.34) |
| Leukemia | 2 | 13.14 (1.59–47.45) | 1 | 2.46 (0.06–13.72) | 2 | 9.45 (1.14–34.12) |
Abbreviations: SIR=standardized incidence ratio; CI=confidence interval.